NIH Expands Undiagnosed Diseases Program

The National Institutes of Health is funding six extramural medical centers to help identify the causes of mysterious diseases.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

FLICKR, RVOEGTLIThe National Institutes of Health (NIH) is giving six additional medical centers a total of $43 million to take part in its Undiagnosed Diseases Network, through which the agency is supporting research to unravel the causes of prolonged, mysterious conditions. The network is an extramural expansion of the agency’s Undiagnosed Diseases Program, which is headquartered at the Clinical Center on the NIH campus in Bethesda, Maryland.

Investigators from the Baylor College of Medicine, Boston Children’s Hospital, Duke University, Stanford University, the University of California, Los Angeles, and the Vanderbilt University Medical Center will now take part in a program that’s using genomic and other approaches, to ascertain the causes of rare, idiopathic conditions.

“We believe that there is a substantial unmet demand for the diagnoses of conditions that have perplexed skillful physicians,” grant recipient Isaac Kohane, a professor of pediatrics at Harvard Medical School and Boston Children’s Hospital, said in an NIH statement. “We want to address inquiries from physicians and patients throughout the country who require these services and, in doing so, create a 21st century model for diagnosis and treatment in this genomic and information-intensive era.”

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Tracy Vence

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo